CA2451663A1 - Method and device for subretinal drug delivery - Google Patents
Method and device for subretinal drug delivery Download PDFInfo
- Publication number
- CA2451663A1 CA2451663A1 CA002451663A CA2451663A CA2451663A1 CA 2451663 A1 CA2451663 A1 CA 2451663A1 CA 002451663 A CA002451663 A CA 002451663A CA 2451663 A CA2451663 A CA 2451663A CA 2451663 A1 CA2451663 A1 CA 2451663A1
- Authority
- CA
- Canada
- Prior art keywords
- piercing member
- cannula
- distal end
- eye
- length
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
Abstract
Devices and devices for the treatment of the eye are disclosed. Preferred devices of the invention include a piercing member (12) that is inserted into the eye to create a pathway for a cannula(44). The cannula (44) is slidably mounted to the piercing member (12) and is adapted to reach a treatment site within the eye at which material is injected into and/or withdrawn from the eye. The outer diameter of the piercing member (12) is small enough to allow for self-sealing of the insertion site of the device upon the device's withdrawal therefrom. Also disclosed are methods for the utilizing the devices to treat the eye.
Claims (35)
- What is claimed is:
A device for treating an eye, comprising:
a piercing member having a length and an outer diameter, the piercing member having proximal end and a distal end and a lumen extending therebetween, the distal end being of sufficient sharpness to penetrate an insertion site of the device;
and a cannula slidably insertable within the piercing member, the cannula having a length longer than the length of the piercing member and having a distal end of sufficient sharpness to penetrate a treatment site, wherein the outer diameter of the piercing member is small enough to allow for self sealing of the insertion site upon removal of the piercing member from the insertion site. - 2. A device for treating an eye, comprising a piercing member and a cannula insertable within the piercing member, the cannula having a length longer than the length of the piercing member.
- 3. The device of claim 1 or 2 further comprising:
a handle having a length, a proximal end and a distal end and a lumen extending therebetween, the distal end of the handle being mounted to the piercing member, and the handle lumen being sized to accommodate the cannula. - 4. The device of any one of claims 1 through 3 wherein the distal end of the piercing member is beveled.
- 5. The device of any one of claims 1 through 4 wherein the outer diameter of the piercing member is about 25 gage.
- 6. The device of any one of claims 1 or 3 through 5 wherein the length of the piercing member is in the range of about 6 millimeters to 40 millimeters, the length of the cannula is in the range of about 35 millimeters to 75 millimeters, and the length of the reduced diameter distal portion of the cannula is in the range of about 1 millimeter to 3 millimeters.
- 7. The device of any one of claims 1 through G wherein the piercing member is made of a stainless steel.
- 8. The device of any one of claims 1 through 7 wherein the cannula is made of polyimide tubing.
- 9. The device of any one of claims 1 through 8 wherein the device is adapted for subretinal delivery of a therapeutic agent to a patient's eye.
- 10. A device for treating an eye, comprising:
a piercing member having a length and an outer diameter, the piercing member having proximal end and a distal end and a lumen extending therebetween, the distal end being of sufficient sharpness to penetrate an insertion site of the device;
a rigid member disposed within the piercing member lumen and having a proximal end and a distal end and a lumen extending therebetween, the rigid member having a length greater than the length of the piercing member;
a cannula disposed within and connected to rigid member lumen, the cannula having a length longer than the length of each of the piercing member and the rigid member, and having a distal end of sufficient sharpness to penetrate a treatment site. - 11. The device of claim 10 further comprising:
a quantity of tubing having a proximal end and a distal end and a lumen extending therebetween, wherein the proximal end of the rigid member is disposed within and connected to the distal end of the tubing. - 12. The device of claim 11 further comprising:
a first connection element having a proximal end and a distal end and a lumen extending therebetween, the distal end of the first connection element being connected to the proximal end of the piercing element. - 13. The device of claim 12 wherein the first connection element lumen and the piercing member lumen are substantially longitudinally aligned.
- 14. The device of claim 12 further comprising:
a seal in communication with the first connection element such that the seal substantially surrounds at least a portion of the first connection element lumen. - 15. The device of any one of claims 10 through 14 wherein the outer diameter of the piercing member is small enough to allow fox self sealing of the insertion site upon removal of the piercing member from the insertion site.
- 16. The device of any one of claims 10 through 14 wherein the distal end of the piercing member is beveled.
- 17. A device for treating an eye, comprising:
a piercing member having a length and an outer diameter, the piercing member having proximal end and a distal end and a lumen extending therebetween, the distal end being of sufficient sharpness to penetrate an insertion site of the device;
a handle having a length, a proximal end and a distal end and a substantially hollow portion, the distal end of the handle being mounted to the piercing member, and the handle lumen being sized to accommodate the outer diameter of the cannula;
a quantity of tubing having a proximal end and a distal end and a lumen extending therebetween, the distal end of the tubing being disposed within the substantially hollow portion of the handle; and a cannula connected to, and disposed at least partially within the tubing lumen, the cannula having an outer diameter such that the cannula is substantially flush with the tubing lumen, and having a distal end of sufficient sharpness to penetrate a treatment site. - 18. The device of claim 17 further comprising:
a housing located within the substantially hollow portion of the handle, the housing being in communication with the distal end of the tubing; and an actuating element in communication with the housing, wherein distal-to-proximal and proximal-to-distal movement of the actuating element are effective to impart corresponding movement to the housing and the tubing. - 19. The device of claim 17 or 18 wherein the distal end of the piercing member is beveled.
- 20. The device of any one of claims 17 through 19 wherein the outer diameter of the piercing member is small enough to allow for self sealing of the insertion site upon removal of the piercing member from the insertion site.
- 21. A medical device kit comprising one or more of the devices of any one of claims 1 through 20.
- 22. The kit of claim 21 wherein one or more of the device sare packaged in sterile condition.
- 23. A method for treating an eye comprising:
inserting into an eye a device comprising a piercing member and a cannula insertable within the piercing member, the cannula having a length longer than the length of the piercing member. - 24. The method of claim 23 wherein a therapeutic agent is administered to a patient's eye through the device.
- 25. The method of claim 23 wherein the therapeutic agent is administered subretinally to the patient's eye.
- 26. The method of any one of claims 23 through 25 wherein the maximum cross-sectional dimension of the portion of the device that pierces a patient's eye is about 25 gage or smaller.
- 27. A method of treating an eye, comprising:
inserting a piercing member having an outer diameter into an insertion site, the piercing member having a proximal end and a distal end and a lumen defined therebetween;
advancing a cannula through the piercing member lumen, the cannula having a proximal end and a distal end;
guiding the cannula to a treatment site;
treating the treatment site;
withdrawing the cannula from the piercing member; and withdrawing the piercing member from the insertion site, wherein the outer diameter of the piercing member is small enough to allow the insertion site to self seal following withdrawal of the piercing member. - 28. The method of claim 27 wherein the step of guiding the cannula to the treatment site comprises:
advancing the cannula within the eye until the distal end of the cannula is within the treatment site. - 29. The method of claim 27 or 28 wherein the step of treating the treatment site comprises:
supplying a medicament through the cannula and into the treatment site via the distal end of the cannula. - 30. The method of any one of claims 27 through 29 wherein the medicament is selected from the group consisting of genes, proteins, cells, small molecule pharmaceuticals and sterile solutions.
- 31. The method of any one of claims 27 through 30 wherein the step of treating the treatment site comprises withdrawing material from the treatment site into the distal end of the cannula.
- 32. The method of any one of claims 27 through 31 wherein the step of inserting the piercing member into the insertion site comprises inserting the distal end of the piercing member into and through the eye's sclera.
- 33. The method of any one of claims 27 through 32 wherein the treatment site is selected from the group consisting of the eye's retina and the eye's vitreous humor.
- 34. The method of any one of claims 27 through 33 wherein the treatment site is the eye's retina and the step of treating the treatment site comprises:
injecting medicament through the cannula and into the retina such that a dome-shaped retinal detachment is formed. - 35. The method of any one of claims 27 through 34 wherein the outer diameter of the piercing member is about 25 gage or smaller.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/888,079 | 2001-06-22 | ||
US09/888,079 US7485113B2 (en) | 2001-06-22 | 2001-06-22 | Method for drug delivery through the vitreous humor |
PCT/US2002/019899 WO2003000312A2 (en) | 2001-06-22 | 2002-06-21 | Method and device for subretinal drug delivery |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2451663A1 true CA2451663A1 (en) | 2003-01-03 |
CA2451663C CA2451663C (en) | 2012-12-04 |
Family
ID=25392484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2451663A Expired - Fee Related CA2451663C (en) | 2001-06-22 | 2002-06-21 | Method and device for subretinal drug delivery |
Country Status (6)
Country | Link |
---|---|
US (2) | US7485113B2 (en) |
EP (1) | EP1404399A4 (en) |
JP (1) | JP4505219B2 (en) |
AU (1) | AU2002316350B2 (en) |
CA (1) | CA2451663C (en) |
WO (1) | WO2003000312A2 (en) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE547080T1 (en) * | 2000-08-30 | 2012-03-15 | Univ Johns Hopkins | DEVICES FOR INTRAOCULAR DRUG DELIVERY |
US7316676B2 (en) * | 2002-08-20 | 2008-01-08 | Gholam A. Peyman | Treatment of retinal detachment |
US20050143363A1 (en) * | 2002-09-29 | 2005-06-30 | Innorx, Inc. | Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases |
US7483750B2 (en) * | 2003-03-21 | 2009-01-27 | Second Sight Medical Products, Inc. | Transretinal implant and method of implantation |
CA2524271C (en) | 2003-05-02 | 2012-09-04 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
US8246974B2 (en) | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
US20060110428A1 (en) * | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
DE102005009694B4 (en) * | 2005-02-28 | 2007-05-03 | Geuder Ag | Ophthalmic set |
WO2006110487A1 (en) | 2005-04-08 | 2006-10-19 | Surmodics, Inc. | Sustained release implants for subretinal delivery |
US20070027452A1 (en) * | 2005-05-18 | 2007-02-01 | Varner Signe E | Insertion instrument for non-linear medical devices |
US20070009564A1 (en) * | 2005-06-22 | 2007-01-11 | Mcclain James B | Drug/polymer composite materials and methods of making the same |
AU2006270221B2 (en) | 2005-07-15 | 2012-01-19 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
EP2019657B1 (en) | 2006-04-26 | 2015-05-27 | Micell Technologies, Inc. | Coatings containing multiple drugs |
JP4872081B2 (en) * | 2006-06-01 | 2012-02-08 | 国立大学法人徳島大学 | Vitreous surgery cannula |
US9539593B2 (en) * | 2006-10-23 | 2017-01-10 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
EP2111184B1 (en) * | 2007-01-08 | 2018-07-25 | Micell Technologies, Inc. | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
JP5443336B2 (en) * | 2007-04-17 | 2014-03-19 | ミセル テクノロジーズ、インコーポレイテッド | Stent with biodegradable layer |
CA2688314C (en) | 2007-05-25 | 2013-12-03 | Micell Technologies, Inc. | Polymer films for medical device coating |
US20090036827A1 (en) | 2007-07-31 | 2009-02-05 | Karl Cazzini | Juxtascleral Drug Delivery and Ocular Implant System |
WO2009051780A1 (en) * | 2007-10-19 | 2009-04-23 | Micell Technologies, Inc. | Drug coated stents |
US8353862B2 (en) * | 2007-11-02 | 2013-01-15 | Allergan, Inc. | Drug delivery systems and methods |
US8602959B1 (en) | 2010-05-21 | 2013-12-10 | Robert Park | Methods and devices for delivery of radiation to the posterior portion of the eye |
US9056201B1 (en) | 2008-01-07 | 2015-06-16 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
US9873001B2 (en) | 2008-01-07 | 2018-01-23 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
KR101634983B1 (en) * | 2008-01-07 | 2016-07-01 | 살루타리스 메디컬 디바이스즈, 인코퍼레이티드 | Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye |
US20110207987A1 (en) * | 2009-11-02 | 2011-08-25 | Salutaris Medical Devices, Inc. | Methods And Devices For Delivering Appropriate Minimally-Invasive Extraocular Radiation |
US8608632B1 (en) | 2009-07-03 | 2013-12-17 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive extraocular delivery of radiation and/or pharmaceutics to the posterior portion of the eye |
US10022558B1 (en) | 2008-01-07 | 2018-07-17 | Salutaris Medical Devices, Inc. | Methods and devices for minimally-invasive delivery of radiation to the eye |
MX350637B (en) * | 2008-04-17 | 2017-09-11 | Micell Technologies Inc | Stents having bioabsorbable layers. |
US20090318856A1 (en) * | 2008-06-18 | 2009-12-24 | Glaser Bert M | Sampling Ocular Fluid |
WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
US7730628B2 (en) * | 2008-09-05 | 2010-06-08 | Bayer Schering Pharma Ag | Depth stop devices and systems |
WO2010062394A2 (en) * | 2008-11-26 | 2010-06-03 | Surmodics, Inc. | Implantable ocular drug delivery device and methods |
US8834913B2 (en) * | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
NL2002379C2 (en) * | 2008-12-29 | 2010-06-30 | D O R C Dutch Ophthalmic Res Ct International B V | An ophthalmic device and an intravitreal method. |
USD691270S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to an eye |
USD691267S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to eye |
USD691268S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to eye |
USD691269S1 (en) | 2009-01-07 | 2013-10-08 | Salutaris Medical Devices, Inc. | Fixed-shape cannula for posterior delivery of radiation to an eye |
EP2410954A4 (en) * | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | Peripheral stents having layers |
WO2010111232A2 (en) | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Drug delivery medical device |
US8287494B2 (en) * | 2009-03-23 | 2012-10-16 | Colin Ma | Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye |
CN102481195B (en) * | 2009-04-01 | 2015-03-25 | 米歇尔技术公司 | Drug delivery medical device |
CA2759015C (en) | 2009-04-17 | 2017-06-20 | James B. Mcclain | Stents having controlled elution |
EP2429607A4 (en) * | 2009-05-15 | 2014-01-08 | Iscience Interventional Corp | Methods and apparatus for sub-retinal catheterization |
JP2013501579A (en) * | 2009-08-10 | 2013-01-17 | サーモディクス,インコーポレイテッド | Methods, devices and compositions for intravitreal injection |
US20110166555A1 (en) * | 2009-09-30 | 2011-07-07 | Jianbo Zhou | Carrier for an insertable medical device, insertion tools, methods of use, and kits |
US20110112469A1 (en) * | 2009-11-08 | 2011-05-12 | Powerscope Incorporated | Device and process for dispensing multiple-phase mixtures |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
EP2515774B1 (en) * | 2009-12-23 | 2014-03-19 | Alcon Research, Ltd. | Ophthalmic valved trocar cannula |
US8343106B2 (en) * | 2009-12-23 | 2013-01-01 | Alcon Research, Ltd. | Ophthalmic valved trocar vent |
WO2011097103A1 (en) * | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
WO2011133655A1 (en) | 2010-04-22 | 2011-10-27 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
US20130172853A1 (en) | 2010-07-16 | 2013-07-04 | Micell Technologies, Inc. | Drug delivery medical device |
US10285852B2 (en) * | 2010-12-02 | 2019-05-14 | Tel Hashomer Medical Research Infrastructure And Services Ltd., The Chaim Sheba Medical Center | Subretinal delivery of therapeutic compositions |
WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
MX351261B (en) | 2012-06-01 | 2017-10-06 | Surmodics Inc | Apparatus and method for coating balloon catheters. |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US9757536B2 (en) | 2012-07-17 | 2017-09-12 | Novartis Ag | Soft tip cannula |
JP6084408B2 (en) * | 2012-09-07 | 2017-02-22 | Hoya株式会社 | Surgical instruments |
CN110269959A (en) | 2013-03-12 | 2019-09-24 | 脉胜医疗技术公司 | Bioabsorbable biomedical implants |
US10272606B2 (en) | 2013-05-15 | 2019-04-30 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
EP3003235B1 (en) * | 2013-05-31 | 2021-09-29 | The Regents of The University of Colorado, A Body Corporate | Devices for creating a predictable capsulorhexis of specific diameter |
AU2015214381C1 (en) * | 2014-02-06 | 2019-06-27 | Alcon Inc. | Manufacturing an articulating ophthalmic surgical probe |
US9949874B2 (en) * | 2014-06-06 | 2018-04-24 | Janssen Biotech, Inc. | Therapeutic agent delivery device with convergent lumen |
US9925088B2 (en) * | 2014-06-06 | 2018-03-27 | Janssen Biotech, Inc. | Sub-retinal tangential needle catheter guide and introducer |
US10391206B2 (en) | 2014-07-30 | 2019-08-27 | University Of Kansas | Cannula for external drainage of subretinal fluid |
USD815285S1 (en) | 2016-05-11 | 2018-04-10 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD814638S1 (en) | 2016-05-11 | 2018-04-03 | Salutaris Medical Devices, Inc. | Brachytherapy device |
USD814637S1 (en) | 2016-05-11 | 2018-04-03 | Salutaris Medical Devices, Inc. | Brachytherapy device |
US10463532B2 (en) | 2016-07-26 | 2019-11-05 | Masatoshi Murata | Method for placing implant in choroid that can less invasively and simply place implant in choroid in optic disc-macula area |
USD808529S1 (en) | 2016-08-31 | 2018-01-23 | Salutaris Medical Devices, Inc. | Holder for a brachytherapy device |
USD808528S1 (en) | 2016-08-31 | 2018-01-23 | Salutaris Medical Devices, Inc. | Holder for a brachytherapy device |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11759355B1 (en) | 2019-02-26 | 2023-09-19 | Gyroscope Therapeutics Limited | Method of delivering leading blebs and agent to subretinal space |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598119A (en) | 1970-02-02 | 1971-08-10 | Charles A White | Continuous paracervical anesthesia method and device |
US3659610A (en) | 1970-04-14 | 1972-05-02 | Hugo S Cimber | Aspirator needle injector |
US4002169A (en) * | 1972-04-18 | 1977-01-11 | Cupler Ii John A | Method and apparatus for performing surgery without tissue incision |
CA1221596A (en) | 1984-03-09 | 1987-05-12 | David Evans | Surgical needle |
US4710171A (en) | 1986-06-09 | 1987-12-01 | The Kendall Company | Needle depth setting sheath assembly and needle stop |
US4781691A (en) | 1987-07-17 | 1988-11-01 | The Kendall Company | Stepped needle |
US4909784A (en) * | 1988-03-25 | 1990-03-20 | Seymour Dubroff | Method for preventing clouding of posterior capsule after extracapsular cataract eye surgery |
US4869717A (en) * | 1988-04-25 | 1989-09-26 | Adair Edwin Lloyd | Gas insufflation needle with instrument port |
US5066276A (en) | 1988-06-21 | 1991-11-19 | Alcon Laboratories, Inc. | Method and apparatus for injecting viscous fluid into the eye to lift pre-retinal and post-retinal membrane with linear pressure control |
US4978334A (en) | 1988-09-08 | 1990-12-18 | Toye Frederic J | Apparatus and method for providing passage into body viscus |
SG49267A1 (en) | 1989-08-14 | 1998-05-18 | Photogenesis Inc | Surgical instrument and cell isolation and transplantation |
JPH0399653A (en) | 1989-09-13 | 1991-04-24 | Terumo Corp | Puncturing needle |
US5273530A (en) | 1990-11-14 | 1993-12-28 | The University Of Rochester | Intraretinal delivery and withdrawal instruments |
JP2660455B2 (en) * | 1991-02-08 | 1997-10-08 | 東洋鋼鈑株式会社 | Heat resistant hard sintered alloy |
US5326345A (en) | 1991-08-14 | 1994-07-05 | Price Jr Francis W | Eye filtration prostheses |
WO1994011042A1 (en) | 1992-11-10 | 1994-05-26 | Seikagaku Kogyo Kabushiki Kaisha | Injector and use of the same |
US5487725A (en) | 1994-05-12 | 1996-01-30 | Syntec, Inc. | Pneumatic vitrectomy for retinal attachment |
US5792099A (en) | 1995-02-14 | 1998-08-11 | Decamp; Dennis | Syringe and cannula for insertion of viscoelastic material into an eye and method of using same |
US6824553B1 (en) * | 1995-04-28 | 2004-11-30 | Target Therapeutics, Inc. | High performance braided catheter |
JPH1085331A (en) * | 1996-07-26 | 1998-04-07 | Asahi Optical Co Ltd | Injection tool for endoscope |
US5984889A (en) | 1996-02-23 | 1999-11-16 | Allergan Sales, Inc. | Apparatus and method for delivering viscoelastic material to an eye |
US5989262A (en) * | 1996-04-15 | 1999-11-23 | Josephberg; Robert Gary | Sutureless pars plana vitrectomy tool |
AUPO394496A0 (en) | 1996-11-29 | 1997-01-02 | Lions Eye Institute | Biological microfistula tube and implantation method and apparatus |
US5871470A (en) | 1997-04-18 | 1999-02-16 | Becton Dickinson And Company | Combined spinal epidural needle set |
DE19725680C2 (en) | 1997-06-18 | 2000-04-06 | Hans Haindl | Funnel-shaped cannula arrangement for catheter insertion |
US5997486A (en) * | 1998-04-24 | 1999-12-07 | Denver Biomaterials, Inc. | Device for paracentisis and thoracentisis |
US6402734B1 (en) | 1998-07-02 | 2002-06-11 | Jeffrey N. Weiss | Apparatus and method for cannulating retinal blood vessels |
US6024719A (en) * | 1998-07-06 | 2000-02-15 | Morris; Robert E | Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS) |
US6309374B1 (en) * | 1998-08-03 | 2001-10-30 | Insite Vision Incorporated | Injection apparatus and method of using same |
US6378526B1 (en) * | 1998-08-03 | 2002-04-30 | Insite Vision, Incorporated | Methods of ophthalmic administration |
US6585972B2 (en) * | 1999-03-09 | 2003-07-01 | Gholam A. Peyman | Process for crosslinking of collagen in the vitreous of the eye and inducing separation of the posterior hyaloid from the retina |
US6319230B1 (en) * | 1999-05-07 | 2001-11-20 | Scimed Life Systems, Inc. | Lateral needle injection apparatus and method |
US6428553B1 (en) * | 2000-03-08 | 2002-08-06 | Nuvue Technologies, Inc. | Illuminated ophthalmic membrane pick assembly |
US6641564B1 (en) * | 2000-11-06 | 2003-11-04 | Medamicus, Inc. | Safety introducer apparatus and method therefor |
US20030171722A1 (en) * | 2001-01-04 | 2003-09-11 | Michel Paques | Microsurgical injection and/or distending instruments and surgical method and apparatus utilizing same |
US7122042B2 (en) * | 2001-03-15 | 2006-10-17 | Lorusso Frank J | Apparatuses and methods for transcleral cautery and subretinal drainage |
US20030158521A1 (en) | 2002-02-21 | 2003-08-21 | Ameri Darius M. | Trocar placement guide needle |
-
2001
- 2001-06-22 US US09/888,079 patent/US7485113B2/en not_active Expired - Fee Related
-
2002
- 2002-06-21 EP EP02746643A patent/EP1404399A4/en not_active Withdrawn
- 2002-06-21 AU AU2002316350A patent/AU2002316350B2/en not_active Ceased
- 2002-06-21 JP JP2003506953A patent/JP4505219B2/en not_active Expired - Fee Related
- 2002-06-21 WO PCT/US2002/019899 patent/WO2003000312A2/en active Application Filing
- 2002-06-21 CA CA2451663A patent/CA2451663C/en not_active Expired - Fee Related
-
2008
- 2008-02-27 US US12/072,652 patent/US20080154204A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003000312A3 (en) | 2003-11-06 |
US20080154204A1 (en) | 2008-06-26 |
AU2002316350B2 (en) | 2008-06-05 |
EP1404399A2 (en) | 2004-04-07 |
US20020198511A1 (en) | 2002-12-26 |
EP1404399A4 (en) | 2008-07-23 |
JP2005516636A (en) | 2005-06-09 |
US7485113B2 (en) | 2009-02-03 |
WO2003000312A2 (en) | 2003-01-03 |
JP4505219B2 (en) | 2010-07-21 |
CA2451663C (en) | 2012-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2451663A1 (en) | Method and device for subretinal drug delivery | |
US6402734B1 (en) | Apparatus and method for cannulating retinal blood vessels | |
AU742031B2 (en) | Catheter system for administration of continuous peripheral nerve anesthetic | |
JP2519873B2 (en) | A catheter / needle assembly and kit for injecting therapeutic agents into the subarachnoid cavity | |
US6936053B1 (en) | Ocular implant needle | |
US6120492A (en) | Method and apparatus for percutaneously accessing an implanted port | |
US8029495B2 (en) | Intrathecal catheter having a stylet with a curved tip and method of use | |
AU2002316350A1 (en) | Method and device for subretinal drug delivery | |
US6863662B2 (en) | Intravenous infusion needle with soft body | |
EP2222355B1 (en) | Meibomian gland intraductal diagnostic and treatment methods and related apparatus | |
US20080108971A1 (en) | Infiltration cannula | |
JPH05505733A (en) | Anesthesia induction method and device | |
US20030135153A1 (en) | Drug implant injection device | |
US20050283124A1 (en) | Needle with slotted tip | |
EP0614676B1 (en) | Catheter apparatus for delivering drugs to the penis | |
EP2247270B1 (en) | Needle for ophthalmic procedures | |
CN101703417A (en) | Fenestrated peripheral nerve block needle and method for using the same | |
US20030229321A1 (en) | Needle with slotted tip | |
JP3685509B2 (en) | Cap for subcutaneous implantable liquid injection port sleeve | |
JP2002500072A (en) | Method and apparatus for disinfecting a subcutaneous implant device | |
US5199946A (en) | Device and method for administering interpleural anesthesia | |
CN218943684U (en) | Eye is through ball back injection needle under ten's bag | |
JPH08150213A (en) | Gene injector | |
RU204832U1 (en) | Intraosseous access device | |
EP2679268A1 (en) | Infusion catheter system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20150622 |